BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7744124)

  • 1. Safety profile of etodolac in the elderly population.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):19-22. PubMed ID: 7744124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
    Veys EM
    Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH; Hsu PN
    Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety profile of sustained-release etodolac.
    Schattenkirchner M
    Rheumatol Int; 1993; 13(2 Suppl):S31-5. PubMed ID: 8210923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose etodolac in rheumatoid arthritis: a review of early studies.
    Spencer-Green G
    J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Bacon P
    Rheumatol Int; 1993; 13(2 Suppl):S7-12. PubMed ID: 8210924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
    Rovenský J; Miceková D
    Drugs Exp Clin Res; 2000; 26(1):19-24. PubMed ID: 10761533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global safety evaluation of etodolac.
    Karbowski A
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():73-9. PubMed ID: 2525986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis.
    Dreiser RL
    Rheumatol Int; 1993; 13(2 Suppl):S13-8. PubMed ID: 8210919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
    Kidd B; Frenzel W
    J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of two double-blind comparative studies with the sustained-release form of etodolac in rheumatoid arthritis.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S25-30. PubMed ID: 8210921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase.
    Todesco S; Del Ross T; Marigliano V; Ariani A
    Int J Clin Pharmacol Res; 1994; 14(1):11-26. PubMed ID: 7927957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.